Laryngeal carcinoma recurrence rate and disease-free interval are related to CD105 expression but not to vascular endothelial growth factor 2 (Flk-1/Kdr) expression

MLA

Marioni, G., et al. Laryngeal Carcinoma Recurrence Rate and Disease-Free Interval Are Related to CD105 Expression but Not to Vascular Endothelial Growth Factor 2 (Flk-1/Kdr) Expression. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....4f8d821348c4e31a01f2c495629abb8f&authtype=sso&custid=ns315887. Accessed 27 Dec. 2024.

APA

Marioni, G., Laura GIACOMELLI, D Alessandro, E., Staffieri, C., Guzzardo, V., Staffieri, A., & Blandamura, S. (n.d.). Laryngeal carcinoma recurrence rate and disease-free interval are related to CD105 expression but not to vascular endothelial growth factor 2 (Flk-1/Kdr) expression.

Chicago

Marioni, G., Laura GIACOMELLI, E. D Alessandro, C. Staffieri, V. Guzzardo, A. Staffieri, and S. Blandamura. 2024. “Laryngeal Carcinoma Recurrence Rate and Disease-Free Interval Are Related to CD105 Expression but Not to Vascular Endothelial Growth Factor 2 (Flk-1/Kdr) Expression.” Accessed December 27. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....4f8d821348c4e31a01f2c495629abb8f&authtype=sso&custid=ns315887.